BILLERICA, Mass.--(BUSINESS WIRE)--
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader
insulin pump technology with its Omnipod® Insulin
Management System, today announced plans to release its financial
results for the second quarter of 2017 on August 3, 2017 after the close
of the financial markets. In connection with the release, management
will host a conference call that day at 4:30 p.m. (Eastern Time).
This Smart News Release features multimedia. View the full release here:
The link to the live call will be available on the Investor Relations
section of the Company's website at http://investors.insulet.com,
"Events and Presentations", and will be archived for future replay. You
may also access the live call by dialing (844) 831-3022 for domestic
callers or (315) 625-6887 for international callers, passcode is
About Insulet Corporation:
Insulet Corporation (NASDAQ: PODD) is an innovative medical device
company dedicated to making the lives of people with diabetes easier.
Through its Omnipod Insulin Management System, Insulet seeks to expand
the use of insulin pump therapy among people with insulin-dependent
diabetes. The Omnipod is a revolutionary and easy-to-use tubeless
insulin pump that provides up to three days of non-stop insulin
delivery, without the need to see or handle a needle. Insulet's Delivery
Systems business also partners with global pharmaceutical and
biotechnology companies to adapt the Omnipod technology platform for the
delivery of subcutaneous drugs across multiple therapeutic areas.
Founded in 2000, Insulet Corporation is based in Billerica,
Massachusetts. For more information, please visit: http://www.myomnipod.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170713005143/en/
Investor Relations and Media Contact:
Vice President, Investor Relations and
Source: Insulet Corporation
News Provided by Acquire Media